Suppr超能文献

癌症放射免疫检测中放射性标记抗体的第二抗体清除

Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection.

作者信息

Sharkey R M, Primus F J, Goldenberg D M

出版信息

Proc Natl Acad Sci U S A. 1984 May;81(9):2843-6. doi: 10.1073/pnas.81.9.2843.

Abstract

The imaging of tumors using radiolabeled antibodies previously has required the implementation of computer-assisted subtraction techniques to reduce background radioactivity. A decrease in radioactivity in the blood of hamsters bearing human colonic tumor xenografts has been achieved by administering a second antibody directed against a radiolabeled primary antibody to carcinoembryonic antigen (CEA). This method was found to reduce the level of blood radioactivity by a factor of 4 within 2 hr after injection of the second antibody and to enhance tumor/nontumor ratios within 24 hr. Unlike liposomally entrapped second antibody, the primary anti-CEA antibody did not show increased accretion of radioactivity in the liver, spleen, or other major organs. These results suggest that administration of a second antibody alone may improve tumor imaging with a radiolabeled antitumor antibody.

摘要

此前,使用放射性标记抗体对肿瘤进行成像需要采用计算机辅助减法技术来降低背景放射性。通过给携带人结肠肿瘤异种移植瘤的仓鼠注射第二种针对放射性标记的癌胚抗原(CEA)一抗的抗体,已实现了仓鼠血液中放射性的降低。发现该方法在注射第二种抗体后2小时内可将血液放射性水平降低4倍,并在24小时内提高肿瘤/非肿瘤比值。与脂质体包裹的第二种抗体不同,一抗CEA抗体在肝脏、脾脏或其他主要器官中未显示放射性积聚增加。这些结果表明,单独给予第二种抗体可能会改善放射性标记抗肿瘤抗体的肿瘤成像效果。

相似文献

引用本文的文献

本文引用的文献

2
The in vivo localization of anti-Wagner-osteogenic-sarcoma antibodies.
Cancer. 1953 May;6(3):619-23. doi: 10.1002/1097-0142(195305)6:3<619::aid-cncr2820060319>3.0.co;2-y.
10
New aspects of liposomes.脂质体的新方面。
Biochim Biophys Acta. 1976 Dec 14;457(3-4):259-302. doi: 10.1016/0304-4157(76)90002-2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验